Notice of Change: Extension of PAR-21-234 "NINDS Faculty Development Award to Promote Diversity in Neuroscience Research (K01 Independent Clinical Trial Not Allowed)"
Notice Number:
NOT-NS-24-056

Key Dates

Release Date:

February 6, 2024

Related Announcements

  • February 6, 2024 - Notice to Rescind NOT-NS-24-038 "Notice of Change: Extension of PAR-21-234 "NINDS Faculty Development Award to Promote Diversity in Neuroscience Research (K01 Independent Clinical Trial Not Allowed)". See Notice NOT-NS-24-057.
  • April 8, 2021 - NINDS Faculty Development Award to Promote Diversity in Neuroscience Research (K01 Independent Clinical Trial Not Allowed). See NOFO PAR-21-234.

Issued by

National Institute of Neurological Disorders and Stroke (NINDS)

Purpose

The purpose of this notice is to inform applications of an extension to PAR-21-234 "NINDS Faculty Development Award to Promote Diversity in Neuroscience Research (K01 Independent Clinical Trial Not Allowed)". This NOFO has been extended by one additional council round. The following application due dates have been added: New Application Due Date: June 12, 2024, Resubmission Application Due Date: July 12, 2024, and AIDS Application Due Date: September 7, 2024. The Expiration date is September 8, 2024. Changes to the NOFO are shown below.

Currently Reads:

Part 1. Overview Information

Key Dates:

Application Due Date(s)


Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. The first standard application due date for this FOA is June 12, 2021.

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

AIDS Application Due Date(s)

Standard AIDS dates apply, by 5:00 PM local time of applicant organization. All types of AIDS and AIDS-related applications allowed for this funding opportunity announcement are due on these dates. The first AIDS application due date for this FOA is May 7, 2021.

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

Scientific Merit ReviewStandard dates apply
Advisory Council ReviewStandard dates apply
Earliest Start DateStandard dates apply
Expiration DateMay 08, 2024

Modified to Read:

Part 1. Overview Information

Key Dates

Application Due Date(s)


Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. The first standard application due date for this FOA is June 12, 2021.

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

AIDS Application Due Date(s)

Standard AIDS dates apply, by 5:00 PM local time of applicant organization. All types of AIDS and AIDS-related applications allowed for this funding opportunity announcement are due on these dates. The first AIDS application due date for this FOA is May 7, 2021.

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

Scientific Merit ReviewStandard dates apply
Advisory Council ReviewStandard dates apply
Earliest Start DateStandard dates apply
Expiration DateSeptember 8, 2024

All other aspects of this NOFO remain unchanged.

Inquiries

Please direct all inquiries to:

Michelle Jones-London, Ph.D.
National Institute of Neurological Disorders and Stroke (NINDS)
Telephone: 301-451-7966
Email: [email protected]

Lauren Ullrich, Ph.D.
National Institute of Neurological Disorders and Stroke (NINDS)
Telephone: 301-451-7964
Email: [email protected]


Weekly TOC for this Announcement
NIH Funding Opportunities and Notices